These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2195779)

  • 1. [Multiple sclerosis--biochemical-immunologic and therapeutic aspects].
    Maciejek Z
    Wiad Lek; 1990 Mar 1-15; 43(5-6):232-9. PubMed ID: 2195779
    [No Abstract]   [Full Text] [Related]  

  • 2. [Current pathogenetic and immunologic aspects of multiple sclerosis].
    Nervenarzt; 1998 Aug; 69(8 Suppl Aktuelle P):1-8. PubMed ID: 9746903
    [No Abstract]   [Full Text] [Related]  

  • 3. [Therapeutic aspects of multiple sclerosis].
    Gonsette RE
    Bull Soc Belge Ophtalmol; 1982; 199-200():275-80. PubMed ID: 7184504
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunologic aspects of multiple sclerosis.
    Taylor RS
    Phys Med Rehabil Clin N Am; 1998 Aug; 9(3):525-36, v. PubMed ID: 9894106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further studies of the allergic nature of multiple sclerosis and the commencement of therapeutic trials.
    Campbell B; Vogel PJ; Fisher E; Lorenz R
    Trans Am Neurol Assoc; 1970; 95():192-5. PubMed ID: 5514365
    [No Abstract]   [Full Text] [Related]  

  • 6. Disease-modifying drugs for the early treatment of multiple sclerosis.
    Flachenecker P
    Expert Rev Neurother; 2004 May; 4(3):455-63. PubMed ID: 15853542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proceedings: Immunologic studies with transfer factor in multiple sclerosis patients.
    Zabriskie JB; Utermohlen V; Espinoza LR; Plank CR; Collins RC
    Neurology; 1975 May; 25(5):490. PubMed ID: 1169711
    [No Abstract]   [Full Text] [Related]  

  • 8. [Prospects of an immunologic therapy of multiple sclerosis].
    Fasanaro G; Gentile A; Stella L
    Acta Neurol (Napoli); 1972; 27(4):367-78. PubMed ID: 5085161
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biochemical and immunologic research in multiple sclerosis].
    Szabó S
    Acta Neurol Psychiatr Belg; 1968 Sep; 68(9):682-704. PubMed ID: 4180713
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunomodulatory therapy in multiple sclerosis].
    Csépány T; Bereczki D
    Ideggyogy Sz; 2004 Nov; 57(11-12):401-16. PubMed ID: 15662768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary.
    Lopez-Diego RS; Weiner HL
    Nat Rev Drug Discov; 2008 Nov; 7(11):909-25. PubMed ID: 18974749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Various immunological aspects of demyelinations. II. Attempts at the determination of immunological reactions in multiple sclerosis].
    Vymazal J; Krásenská-Dlabacová J
    Cesk Neurol Neurochir; 1974 Jul; 37(4):240-6. PubMed ID: 4846373
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunopathogenesis and immunotherapeutic approaches in multiple sclerosis.
    Lim ET; Giovannoni G
    Expert Rev Neurother; 2005 May; 5(3):379-90. PubMed ID: 15938671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic aspects of multiple sclerosis.
    Ansari K
    Minn Med; 1970 Jul; 53(7):799-803. PubMed ID: 5427690
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunological questions on hematopoietic stem cell transplantation for multiple sclerosis.
    Muraro PA; Martin R
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S41-4. PubMed ID: 12931240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid hormones in multiple sclerosis.
    El-Etr M; Vukusic S; Gignoux L; Durand-Dubief F; Achiti I; Baulieu EE; Confavreux C
    J Neurol Sci; 2005 Jun; 233(1-2):49-54. PubMed ID: 15878598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapeutic immunomodulation in neurology: from hope to reality. Exemplified by multiple sclerosis].
    Schluep M; Regli F
    Praxis (Bern 1994); 1995 Sep; 84(38):1021-4. PubMed ID: 7481299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic reactivity and arachidonic acid metabolism in patients with multiple sclerosis. Study of mononuclear leukocyte adherence inhibition].
    Mayer M
    Cesk Neurol Neurochir; 1986 Nov; 49(6):397-401. PubMed ID: 3100067
    [No Abstract]   [Full Text] [Related]  

  • 19. Design and synthesis of a cyclic double mutant peptide (cyclo(87-99)[A91,A96]MBP87-99) induces altered responses in mice after conjugation to mannan: implications in the immunotherapy of multiple sclerosis.
    Katsara M; Deraos G; Tselios T; Matsoukas MT; Friligou I; Matsoukas J; Apostolopoulos V
    J Med Chem; 2009 Jan; 52(1):214-8. PubMed ID: 19072222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potassium channels, memory T cells, and multiple sclerosis.
    Beeton C; Chandy KG
    Neuroscientist; 2005 Dec; 11(6):550-62. PubMed ID: 16282596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.